In ovarian cancer, further functional experiments are required to determine whether increased PRKDC influences the NHEJ pathway, while elucidation of the underlying molecular mechanism linking PRKDC to chromosome instability in ovarian cancer is necessary for its potential application. The gene discussed is PRKDC; the disease is ovarian cancer.